Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Role of astrocytes in pain.

Chiang CY, Sessle BJ, Dostrovsky JO.

Neurochem Res. 2012 Nov;37(11):2419-31. doi: 10.1007/s11064-012-0801-6. Review.

PMID:
22638776
2.

Current challenges in glia-pain biology.

McMahon SB, Malcangio M.

Neuron. 2009 Oct 15;64(1):46-54. doi: 10.1016/j.neuron.2009.09.033. Review.

3.

Spinal glial activation contributes to pathological pain states.

Cao H, Zhang YQ.

Neurosci Biobehav Rev. 2008 Jul;32(5):972-83. doi: 10.1016/j.neubiorev.2008.03.009. Review.

PMID:
18471878
5.

The role of glia and the immune system in the development and maintenance of neuropathic pain.

Vallejo R, Tilley DM, Vogel L, Benyamin R.

Pain Pract. 2010 May-Jun;10(3):167-84. doi: 10.1111/j.1533-2500.2010.00367.x. Review.

PMID:
20384965
7.

Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome.

Del Valle L, Schwartzman RJ, Alexander G.

Brain Behav Immun. 2009 Jan;23(1):85-91. doi: 10.1016/j.bbi.2008.08.004.

PMID:
18786633
8.

Involvement of glia in central sensitization in trigeminal subnucleus caudalis (medullary dorsal horn).

Xie YF, Zhang S, Chiang CY, Hu JW, Dostrovsky JO, Sessle BJ.

Brain Behav Immun. 2007 Jul;21(5):634-41.

PMID:
17055698
9.

Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor.

Maeda J, Higuchi M, Inaji M, Ji B, Haneda E, Okauchi T, Zhang MR, Suzuki K, Suhara T.

Brain Res. 2007 Jul 9;1157:100-11.

PMID:
17540348
10.

The role of tachykinins in central nervous system inflammatory responses.

Marriott I.

Front Biosci. 2004 Sep 1;9:2153-65. Review.

PMID:
15353277
11.

Glial activation and pathological pain.

Wieseler-Frank J, Maier SF, Watkins LR.

Neurochem Int. 2004 Jul-Aug;45(2-3):389-95. Review.

PMID:
15145553
12.

A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity.

Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, Choi SY, Park K, Kim JS, Akira S, Na HS, Oh SB, Lee SJ.

J Biol Chem. 2007 May 18;282(20):14975-83.

13.

Metabotropic glutamate receptors in glial cells.

D'Antoni S, Berretta A, Bonaccorso CM, Bruno V, Aronica E, Nicoletti F, Catania MV.

Neurochem Res. 2008 Dec;33(12):2436-43. doi: 10.1007/s11064-008-9694-9. Review.

PMID:
18438710
14.

Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems.

Carnevale D, De Simone R, Minghetti L.

CNS Neurol Disord Drug Targets. 2007 Dec;6(6):388-97. Review.

PMID:
18220778
15.

Immune and glial cell factors as pain mediators and modulators.

McMahon SB, Cafferty WB, Marchand F.

Exp Neurol. 2005 Apr;192(2):444-62. Review.

PMID:
15755561
16.

Glial reactions in Parkinson's disease.

McGeer PL, McGeer EG.

Mov Disord. 2008 Mar 15;23(4):474-83. Review.

PMID:
18044695
17.

Could chronic pain and spread of pain sensation be induced and maintained by glial activation?

Hansson E.

Acta Physiol (Oxf). 2006 May-Jun;187(1-2):321-7. Review.

PMID:
16734769
18.

Spinal astrocytes in pain processing: non-neuronal cells as therapeutic targets.

Svensson CI, Brodin E.

Mol Interv. 2010 Feb;10(1):25-38. doi: 10.1124/mi.10.1.6. Review.

PMID:
20124561
19.

Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF.

Brain Behav Immun. 2007 Feb;21(2):131-46.

20.

Glial neuronal signaling in the central nervous system.

Hansson E, Rönnbäck L.

FASEB J. 2003 Mar;17(3):341-8. Review.

Items per page

Supplemental Content

Support Center